Across TCGA pan-cancer cohorts, C1QTNF12 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated C1QTNF12 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher C1QTNF12 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated C1QTNF12 expression acts as an unfavorable survival marker.

COAD, PRAD, and SCLC are the cancer types where C1QTNF12 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	III,IV	0.133	0.783	<.001	12	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →
SCLC	OS	Median	All	0.219	0.706	.011	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: C1QTNF12 tumor-vs-normal RNA expression · all C1QTNF12 data types